Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
Eton Pharmaceuticals, Inc (Nasdaq: ETON) will present at the Citizens JMP Life Sciences Conference in New York on May 13, 2024. Sean Brynjelsen, CEO, and James Gruber, CFO, will participate. For meeting requests, contact Citizens JMP.
- None.
- None.
DEER PARK, Ill., May 01, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced today that Sean Brynjelsen, Chief Executive Officer, and James Gruber, Chief Financial Officer, will present at the Citizens JMP Life Sciences Conference in New York as follows:
| Date: | Monday, May 13, 2024 |
| Time: | 10:00am ET |
| Webcast: | Click Here |
To schedule a 1x1 meeting with the Company, please contact your Citizens JMP institutional sales representative.
About Eton Pharmaceuticals
Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has five commercial rare disease products: ALKINDI SPRINKLE®, PKU GOLIKE®, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO® hydrocortisone autoinjector. For more information, please visit our website at www.etonpharma.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Source: Eton Pharmaceuticals.
FAQ
When will Eton Pharmaceuticals present at the Citizens JMP Life Sciences Conference?
Who will be representing Eton Pharmaceuticals at the conference?
Where will the Citizens JMP Life Sciences Conference take place?
How can one schedule a meeting with Eton Pharmaceuticals during the conference?
